How a Site-Centric Delivery Model Accelerated Study Start-Up

When a Phase II Parkinson’s disease study faced aggressive start-up and enrollment targets, the study team was tasked with achieving first patient consent within just eight weeks of final protocol release. The trial’s hybrid design, incorporating both in-clinic and at-home treatment, combined with the challenges of recruiting patients experiencing fluctuating OFF episodes, created significant operational complexity and timeline pressure.

This case study demonstrates how a focused operational strategy, leveraging accelerated start-up execution, targeted site selection, proactive patient identification, and close coordination across stakeholders, helped drive early recruitment momentum and exceed sponsor enrollment milestones despite protocol changes and evolving study demands.

Download the full case study to learn how strategic site engagement, operational agility, and specialized neurology trial expertise can accelerate study start-up and support successful delivery in complex Parkinson’s disease clinical research programs.

Name(Required)